Henrik Ljung

Supplies luncheon meat products and frozen food

MIAB's investment objective is to create value in their portfolio firms. Their investment strategy focuses on small to mid-sized technology-based firms primarily in the Öresund region of Sweden and Denmark. They look for developing firms in the expansion-phase. MIAB is an active investment partner. They typically take minority stakes. They seek to strengthen the portfolio firms' balance sheet, broaden their skills and widen their network to enable them to create value and sell at the appropriate time. They have invested in orally administered contrast medium for scanning of liver tumors by magnetic resonance imaging (MRI), therapeutic solutions for cancer treatment, development of molecularly imprinted polymers (MIPs), injectable filler for aesthetic surgery, allergy diagnostics and management, time-temperature system for monitoring the accumulated effect of temperature on products, and electroporation for research and laboratory use in vivo and in vitro.

Functions as a College/University

Provides administrative services, process development and information technology solutions

Develops and provides equipment for cancer treatment

Provides control technologies for the commercial bio-gas industry

Develops biomedical devices

Manufactures and retails kitchen and bathroom products

Develops, manufactures, and licenses imaging based on nanoparticles